Literature DB >> 10211420

Simple method for DNA extraction from pancreatic juice for PCR amplification assays.

P Müller1, R Jesnowski, S Liebe, A Rolfs, M Löhr.   

Abstract

CONCLUSION: Preparation of DNA from pancreatic juice for subsequent polymerase chain reaction (PCR) is difficult, but manageable. The protocol presented offers a simple and fast solution. This method might be applicable to other complicated samples, such as saliva, would secretions, or stool washings.
BACKGROUND: Of all the biological samples used for PCR amplification, pancreatic juice is the most problematic because of the presence of potential inhibitory substances and the amount of nucleases. This demands a DNA preparation procedure that is suitable for routine diagnostic PCR, and is therefore efficient and safe. This is particularly true for pancreatic juice obtained during routine endoscopy.
METHODS: We describe here a simple method utilizing modified phenol/chloroform extraction and precipitation directly from native pancreatic juice suitable for diagnostic PCR applications, such as oncogenes.
RESULTS: DNA could be prepared in quantitative amounts from routine endoscopic specimens. DNA could also be prepared from samples kept several days at room temperature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211420     DOI: 10.1385/IJGC:25:1:39

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  14 in total

Review 1.  Application of the polymerase chain reaction in gastroenterological endoscopy.

Authors:  M Löhr; D A Brenner; J F Rooney; J A Nelson
Journal:  Endoscopy       Date:  1992-11       Impact factor: 10.093

2.  Myoglobin as a polymerase chain reaction (PCR) inhibitor: a limitation for PCR from skeletal muscle tissue avoided by the use of Thermus thermophilus polymerase.

Authors:  L Bélec; J Authier; M C Eliezer-Vanerot; C Piédouillet; A S Mohamed; R K Gherardi
Journal:  Muscle Nerve       Date:  1998-08       Impact factor: 3.217

3.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

4.  Assessment of endoscopic retrograde cholangio-pancreatography (ERCP) and pure pancreatic juice cytology in patients with pancreatic disease.

Authors:  A R Hatfield; A Smithies; R Wilkins; A J Levi
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

5.  Isolation, culture, and characterization of human pancreatic duct cells.

Authors:  B Trautmann; H J Schlitt; E G Hahn; M Löhr
Journal:  Pancreas       Date:  1993-03       Impact factor: 3.327

Review 6.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Inhibition of PCR by aqueous and vitreous fluids.

Authors:  D L Wiedbrauk; J C Werner; A M Drevon
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes.

Authors:  J M Löhr; M B Oldstone
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

9.  [Restriction enzyme mismatch polymerase chain reaction in the demonstration of Ki-ras-oncogene mutation in carcinoma of the pancreas].

Authors:  T Heller; B Trautmann; I Zöller-Utz; H J König; S Liebe; C Ell; M Löhr
Journal:  Dtsch Med Wochenschr       Date:  1995-06-09       Impact factor: 0.628

10.  Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.

Authors:  M Löhr; B Trautmann; M Göttler; S Peters; I Zauner; B Maillet; G Klöppel
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  3 in total

1.  No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis.

Authors:  C Di Campli; R Nocente; G Costamagna; N Gentiloni; R Burioni; J Wu; A Armuzzi; M A Zern; G Gasbarrini; A Gasbarrini
Journal:  Int J Pancreatol       Date:  2000-12

Review 2.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

3.  APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors.

Authors:  Mireia M Ginesta; Zamira Vanessa Diaz-Riascos; Juli Busquets; Núria Pelaez; Teresa Serrano; Miquel Àngel Peinado; Rosa Jorba; Francisco Javier García-Borobia; Gabriel Capella; Joan Fabregat
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.